SCHEMBL3833570

SCHEMBL3833570

NC(=S)N(CF)c1ccccc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.54
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
GLA P06280 1/20 0.39
TSHR P16473 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ADRA2C P18825 1/20 0.36
FAAH O00519 1/20 0.35
PHGDH O43175 1/20 0.35
MGLL Q99685 1/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27552754 0.81 ALDH1A1 (0.56) ALDH1A1MEN1KMT2AGLATSHR
SCHEMBL5255040 0.79 ALDH1A1 (0.53) ALDH1A1MEN1KMT2AGLATSHR
SCHEMBL145553 0.79 ALDH1A1 (0.59) ALDH1A1MEN1KMT2AGLATSHR
SCHEMBL11816669 0.78 ALDH1A1 (0.52) ALDH1A1MEN1KMT2AGLATSHR
SCHEMBL16718679 0.78 ALDH1A1 (0.53) ALDH1A1MEN1KMT2AGLATSHR
SCHEMBL6920739 0.76 ALDH1A1 (0.50) ALDH1A1MEN1KMT2AGLATSHR
SCHEMBL16698514 0.75 ALDH1A1 (0.48) ALDH1A1L3MBTL1HPGDSMN1; SMN2
SCHEMBL7450023 0.75 ALDH1A1 (0.48) ALDH1A1MEN1KMT2AGLATSHR
SCHEMBL28696312 0.75 ALDH1A1 (0.48) ALDH1A1MEN1KMT2AGLATSHR
SCHEMBL6743229 0.75 ALDH1A1 (0.48) ALDH1A1MEN1KMT2AGLATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2091524-A2 COMBINATION THERAPY FOR TREATING HEPATITIS C INFECTIONS Achillion Pharmaceuticals, Inc. (US) 2009-08-26 EP claimed
WO-2008076443-A2 COMBINATION THERAPY FOR TREATING HEPATITIS C INFECTIONS ACHILLION PHARMACEUTICALS, INC. (US) 2008-06-26 WO claimed